The Role of 2-tert-Butylanthracene in API Synthesis and Drug Discovery
In the intricate world of pharmaceutical development, the selection of the right chemical intermediates is a cornerstone of success. 2-tert-Butylanthracene, identified by its CAS number 18801-00-8, stands out as a critical component in the synthesis of Active Pharmaceutical Ingredients (APIs) and plays a substantial role in drug discovery initiatives. As a supplier of high-purity fine chemicals, we understand the exacting demands of this sector.
Understanding 2-tert-Butylanthracene's Chemical Profile
2-tert-Butylanthracene is a polycyclic aromatic hydrocarbon derivative. Its chemical structure, featuring an anthracene core with a tert-butyl substituent, imparts unique reactivity and solubility characteristics. With a molecular formula of C18H18 and a molecular weight of 234.34 g/mol, it is typically supplied as a light yellow powder with a purity standard of ≥99%. This high purity is essential for its use in regulated pharmaceutical manufacturing processes, minimizing unwanted side reactions and ensuring the integrity of the final API.
Contribution to API Synthesis
The journey from raw materials to a finished API is often a multi-step process involving complex organic reactions. 2-tert-Butylanthracene serves as a valuable building block or synthon in these pathways. Its anthracene moiety can undergo various functionalization reactions, while the tert-butyl group can influence steric and electronic properties, guiding regioselectivity and enhancing the stability of intermediate compounds. Pharmaceutical chemists leverage these attributes to efficiently construct complex molecular architectures required for targeted therapeutic action. For manufacturers looking to buy this intermediate, ensuring a reliable supply from a reputable source, such as a dedicated Chinese manufacturer, is crucial for maintaining production continuity.
Impact on Drug Discovery
In the early stages of drug discovery, rapid synthesis and screening of diverse compound libraries are common. 2-tert-Butylanthracene, as a readily available and versatile intermediate, facilitates the creation of novel chemical scaffolds. Its incorporation into potential drug candidates can lead to compounds with improved pharmacokinetic properties, enhanced target binding affinity, or altered metabolic profiles. Researchers can source this compound for their exploratory synthesis, potentially leading to the identification of new therapeutic agents. Companies seeking to procure this material for R&D purposes can benefit from competitive pricing and efficient delivery from experienced chemical suppliers.
Sourcing Considerations for Pharmaceutical Professionals
When procuring 2-tert-Butylanthracene for pharmaceutical applications, several factors are critical. The purity of the material is paramount, as impurities can affect downstream reactions and the final product's safety and efficacy. Working with manufacturers who provide comprehensive documentation, including Certificates of Analysis (CoA), is essential. Furthermore, establishing a strong relationship with a supplier that guarantees consistent quality and timely delivery, like NINGBO INNO PHARMCHEM, ensures that your drug development timelines are met without interruption. We are committed to being a trusted partner for your API synthesis and drug discovery needs.
Perspectives & Insights
Future Origin 2025
“Understanding 2-tert-Butylanthracene's Chemical Profile2-tert-Butylanthracene is a polycyclic aromatic hydrocarbon derivative.”
Core Analyst 01
“Its chemical structure, featuring an anthracene core with a tert-butyl substituent, imparts unique reactivity and solubility characteristics.”
Silicon Seeker One
“34 g/mol, it is typically supplied as a light yellow powder with a purity standard of ≥99%.”